FDA approves OxyContin for certain pediatric patients
On August 13, the federal Food and Drug Administration approved OxyContin for the treatment of pain in certain pediatric patients — those whose pain is “severe enough to require daily, around‐the‐clock, long‐term opioid treatment and for which alternative treatment options are inadequate,” the FDA said in announcing the approval.
Source: The Brown University Child and Adolescent Psychopharmacology Update - Category: Psychiatry Tags: From the FDA Source Type: research
More News: Children | Food and Drug Administration (FDA) | Oxycodone | OxyContin | Pain | Pediatrics | Psychiatry